Pharmacokinetic and Comparative Bioavailability Study of Codeine Sulfate Under Fasted Conditions
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study designed to characterize the pharmacokinetics and comparative
bioavailability of Roxane Laboratories' codeine sulfate tablets after oral administration of
60 mg doses as 1 x 60 mg, 2 x 30 mg and 4 x 15 mg under fasted conditions.